HEADER HYDROLASE INHIBITOR 13-OCT-08 3EVJ TITLE INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL TITLE 2 PENTASACCHARIDE CAVEAT 3EVJ MAN A 3 HAS WRONG CHIRALITY AT ATOM C1 MAN D 3 HAS WRONG CAVEAT 2 3EVJ CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTITHROMBIN-III; COMPND 3 CHAIN: I, L; COMPND 4 SYNONYM: ATIII SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: ALPHA ANTITHROMBIN FROM FRESH-FROZEN PLASMA KEYWDS SERPIN, HEPARIN, BLOOD COAGULATION, DISEASE MUTATION, GLYCOPROTEIN, KEYWDS 2 HEPARIN-BINDING, PROTEASE INHIBITOR, SECRETED, SERINE PROTEASE KEYWDS 3 INHIBITOR, THROMBOPHILIA, HYDROLASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.A.HUNTINGTON,K.J.BELZAR REVDAT 7 06-SEP-23 3EVJ 1 REMARK HETSYN REVDAT 6 29-JUL-20 3EVJ 1 CAVEAT COMPND REMARK HET REVDAT 6 2 1 HETNAM HETSYN FORMUL LINK REVDAT 6 3 1 SITE ATOM REVDAT 5 12-JUL-17 3EVJ 1 CAVEAT HETSYN REVDAT 4 21-JUN-17 3EVJ 1 JRNL REVDAT 3 13-JUL-11 3EVJ 1 VERSN REVDAT 2 24-FEB-09 3EVJ 1 VERSN REVDAT 1 21-OCT-08 3EVJ 0 JRNL AUTH J.LANGDOWN,K.J.BELZAR,W.J.SAVORY,T.P.BAGLIN,J.A.HUNTINGTON JRNL TITL THE CRITICAL ROLE OF HINGE-REGION EXPULSION IN THE JRNL TITL 2 INDUCED-FIT HEPARIN BINDING MECHANISM OF ANTITHROMBIN. JRNL REF J. MOL. BIOL. V. 386 1278 2009 JRNL REFN ESSN 1089-8638 JRNL PMID 19452598 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 63.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 824257.570 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 20055 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : TAKEN FROM 2ANT REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1016 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3163 REMARK 3 BIN R VALUE (WORKING SET) : 0.3290 REMARK 3 BIN FREE R VALUE : 0.3580 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 153 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6164 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 365 REMARK 3 SOLVENT ATOMS : 45 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 93.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.65000 REMARK 3 B22 (A**2) : -2.22000 REMARK 3 B33 (A**2) : -7.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -23.69000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.59 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.50 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.70 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.250 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.210 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.640 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.650 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 64.50 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : PENTA_NEW.PAR REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : PENTA_NEW.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3EVJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049819. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-SEP-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : SI (111) CRYTALS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20068 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 63.250 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.11600 REMARK 200 R SYM (I) : 0.11600 REMARK 200 FOR THE DATA SET : 3.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.52300 REMARK 200 R SYM FOR SHELL (I) : 0.52300 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1NQ9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200MM NH4F, 20% PEG 3350, PH 7.0, REMARK 280 EVAPORATION, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.52750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, L, A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 SER I 3 REMARK 465 PRO I 4 REMARK 465 VAL I 5 REMARK 465 GLU I 27 REMARK 465 LYS I 28 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 GLN I 38 REMARK 465 ASN I 135 REMARK 465 LYS I 136 REMARK 465 PHE I 175 REMARK 465 LYS I 176 REMARK 465 GLU I 177 REMARK 465 ASN I 178 REMARK 465 GLU I 357 REMARK 465 GLY I 358 REMARK 465 ARG I 359 REMARK 465 ASP I 360 REMARK 465 LYS I 432 REMARK 465 HIS L 1 REMARK 465 GLY L 2 REMARK 465 SER L 3 REMARK 465 PRO L 4 REMARK 465 SER L 25 REMARK 465 PRO L 26 REMARK 465 GLU L 27 REMARK 465 LYS L 28 REMARK 465 LYS L 29 REMARK 465 ALA L 30 REMARK 465 THR L 31 REMARK 465 GLU L 32 REMARK 465 ASP L 33 REMARK 465 ASN L 396 REMARK 465 LYS L 432 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS I 11 CD CE NZ REMARK 470 ILE I 15 CG1 CG2 CD1 REMARK 470 MET I 17 CG SD CE REMARK 470 SER I 25 OG REMARK 470 LYS I 39 CG CD CE NZ REMARK 470 ILE I 40 CG1 CG2 CD1 REMARK 470 ARG I 46 CG CD NE CZ NH1 NH2 REMARK 470 LYS I 53 CE NZ REMARK 470 ARG I 57 CG CD NE CZ NH1 NH2 REMARK 470 LYS I 91 CG CD CE NZ REMARK 470 LYS I 125 CG CD CE NZ REMARK 470 LEU I 130 CG CD1 CD2 REMARK 470 TYR I 131 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG I 132 NE CZ NH1 NH2 REMARK 470 LYS I 133 CG CD CE NZ REMARK 470 SER I 137 OG REMARK 470 SER I 138 OG REMARK 470 LYS I 139 CG CD CE NZ REMARK 470 ARG I 145 CG CD NE CZ NH1 NH2 REMARK 470 SER I 162 OG REMARK 470 GLU I 163 CG CD OE1 OE2 REMARK 470 LEU I 164 CD1 CD2 REMARK 470 VAL I 165 CG1 CG2 REMARK 470 LYS I 169 CG CD CE NZ REMARK 470 LEU I 173 CG CD1 CD2 REMARK 470 ASP I 174 CG OD1 OD2 REMARK 470 SER I 182 OG REMARK 470 ARG I 183 CD NE CZ NH1 NH2 REMARK 470 LYS I 188 CG CD CE NZ REMARK 470 LYS I 193 CG CD CE NZ REMARK 470 ILE I 207 CG1 CG2 CD1 REMARK 470 LEU I 210 CG CD1 CD2 REMARK 470 THR I 211 OG1 CG2 REMARK 470 VAL I 212 CG1 CG2 REMARK 470 LYS I 222 CG CD CE NZ REMARK 470 GLU I 232 CG CD OE1 OE2 REMARK 470 ARG I 235 CG CD NE CZ NH1 NH2 REMARK 470 LYS I 236 NZ REMARK 470 LYS I 257 CG CD CE NZ REMARK 470 ARG I 259 CD NE CZ NH1 NH2 REMARK 470 VAL I 263 CG1 CG2 REMARK 470 LYS I 275 CG CD CE NZ REMARK 470 LYS I 287 CG CD CE NZ REMARK 470 GLU I 289 CG CD OE1 OE2 REMARK 470 LYS I 294 CG CD CE NZ REMARK 470 LYS I 297 CG CD CE NZ REMARK 470 GLU I 306 CD OE1 OE2 REMARK 470 LEU I 308 CG CD1 CD2 REMARK 470 GLU I 310 CG CD OE1 OE2 REMARK 470 GLU I 312 CG CD OE1 OE2 REMARK 470 ARG I 324 CG CD NE CZ NH1 NH2 REMARK 470 GLU I 326 CD OE1 OE2 REMARK 470 LYS I 348 CG CD CE NZ REMARK 470 LYS I 350 CG CD CE NZ REMARK 470 ASP I 361 CG OD1 OD2 REMARK 470 TYR I 363 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS I 370 CG CD CE NZ REMARK 470 VAL I 388 CG1 CG2 REMARK 470 VAL I 389 CG1 CG2 REMARK 470 VAL I 431 CG1 CG2 REMARK 470 VAL L 5 CG1 CG2 REMARK 470 ILE L 7 CG1 CG2 CD1 REMARK 470 LYS L 11 CG CD CE NZ REMARK 470 ARG L 13 CG CD NE CZ NH1 NH2 REMARK 470 ASP L 14 CG OD1 OD2 REMARK 470 MET L 17 CG SD CE REMARK 470 ILE L 22 CG1 CG2 CD1 REMARK 470 GLN L 38 CD OE1 NE2 REMARK 470 LYS L 39 CG CD CE NZ REMARK 470 ILE L 40 CG1 CG2 CD1 REMARK 470 THR L 44 OG1 CG2 REMARK 470 ARG L 46 CG CD NE CZ NH1 NH2 REMARK 470 LYS L 53 CG CD CE NZ REMARK 470 GLN L 100 CG CD OE1 NE2 REMARK 470 LYS L 107 CE NZ REMARK 470 GLU L 113 CG CD OE1 OE2 REMARK 470 SER L 116 OG REMARK 470 ARG L 129 CG CD NE CZ NH1 NH2 REMARK 470 ARG L 132 CG CD NE CZ NH1 NH2 REMARK 470 LYS L 133 CG CD CE NZ REMARK 470 LYS L 136 CG CD CE NZ REMARK 470 SER L 137 OG REMARK 470 SER L 138 OG REMARK 470 LYS L 150 CG CD CE NZ REMARK 470 GLU L 180 CG CD OE1 OE2 REMARK 470 GLN L 181 CG CD OE1 NE2 REMARK 470 LYS L 188 NZ REMARK 470 ASP L 200 CG OD1 OD2 REMARK 470 GLU L 205 CG CD OE1 OE2 REMARK 470 LYS L 228 CD CE NZ REMARK 470 LYS L 236 CG CD CE NZ REMARK 470 LYS L 241 NZ REMARK 470 GLU L 245 CG CD OE1 OE2 REMARK 470 LYS L 257 CG CD CE NZ REMARK 470 ARG L 261 CD NE CZ NH1 NH2 REMARK 470 ARG L 262 CG CD NE CZ NH1 NH2 REMARK 470 LYS L 275 CG CD CE NZ REMARK 470 LYS L 287 CG CD CE NZ REMARK 470 GLU L 289 CG CD OE1 OE2 REMARK 470 LYS L 290 CG CD CE NZ REMARK 470 LYS L 294 CG CD CE NZ REMARK 470 GLU L 298 CG CD OE1 OE2 REMARK 470 GLU L 312 CG CD OE1 OE2 REMARK 470 VAL L 341 CG1 CG2 REMARK 470 LYS L 348 CE NZ REMARK 470 LEU L 395 CG CD1 CD2 REMARK 470 ARG L 399 CG CD NE CZ NH1 NH2 REMARK 470 PHE L 402 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS L 403 CD CE NZ REMARK 470 ARG L 406 CG CD NE CZ NH1 NH2 REMARK 470 VAL L 415 CG1 CG2 REMARK 470 VAL L 431 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ILE I 186 N TRP I 189 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY L 35 N - CA - C ANGL. DEV. = 15.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA I 10 -137.99 -58.23 REMARK 500 LYS I 11 136.72 -178.41 REMARK 500 PRO I 16 114.24 -29.53 REMARK 500 MET I 17 54.05 -143.90 REMARK 500 ALA I 43 65.65 12.41 REMARK 500 ALA I 86 -70.58 -50.02 REMARK 500 MET I 89 -80.23 -70.29 REMARK 500 THR I 90 -39.23 -31.32 REMARK 500 LYS I 91 29.09 -65.67 REMARK 500 ASN I 96 -145.15 67.02 REMARK 500 THR I 110 47.80 -93.17 REMARK 500 SER I 112 161.34 -46.97 REMARK 500 GLN I 118 46.70 -94.93 REMARK 500 ARG I 132 7.04 -67.85 REMARK 500 LEU I 173 -83.86 -147.50 REMARK 500 ILE I 186 -91.65 -60.36 REMARK 500 ASN I 187 -40.74 -28.58 REMARK 500 GLU I 195 63.33 35.33 REMARK 500 ASP I 200 62.01 29.70 REMARK 500 GLU I 205 36.30 -142.09 REMARK 500 ASN I 208 -157.08 -176.60 REMARK 500 GLU I 209 8.80 -69.07 REMARK 500 VAL I 212 -84.66 -89.36 REMARK 500 GLU I 232 22.83 -74.61 REMARK 500 ASN I 233 10.04 -141.29 REMARK 500 ARG I 235 -152.27 -79.83 REMARK 500 LYS I 236 43.96 -141.71 REMARK 500 GLU I 237 178.43 -50.47 REMARK 500 GLN I 254 141.23 -172.93 REMARK 500 ARG I 261 127.10 178.34 REMARK 500 THR I 267 126.76 -24.90 REMARK 500 LEU I 308 0.31 -68.84 REMARK 500 PHE I 323 149.62 -179.99 REMARK 500 LYS I 332 -72.89 -41.93 REMARK 500 PHE I 344 45.00 -100.02 REMARK 500 GLU I 347 70.98 -111.03 REMARK 500 LYS I 348 -20.84 173.27 REMARK 500 SER I 349 -175.07 -56.39 REMARK 500 LYS I 350 78.31 176.85 REMARK 500 GLU I 377 -40.51 -29.38 REMARK 500 GLU I 381 -23.31 60.65 REMARK 500 CYS I 430 -158.84 -55.52 REMARK 500 PRO L 12 6.18 -64.27 REMARK 500 ASP L 14 -23.80 -156.84 REMARK 500 ILE L 15 45.57 -149.62 REMARK 500 PRO L 19 -126.23 -86.71 REMARK 500 MET L 20 -30.81 -140.26 REMARK 500 SER L 36 39.36 -145.69 REMARK 500 GLU L 37 102.08 -47.23 REMARK 500 LYS L 39 43.87 -142.96 REMARK 500 REMARK 500 THIS ENTRY HAS 95 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR I 63 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 NAG I 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NQ9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND REMARK 900 INTERMEDIATE STATE REMARK 900 RELATED ID: 2B5T RELATED DB: PDB REMARK 900 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN REMARK 900 ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A REMARK 900 THROMBIN MOLECULES DBREF 3EVJ I 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 3EVJ L 1 432 UNP P01008 ANT3_HUMAN 33 464 SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS SEQRES 1 L 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 L 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 L 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 L 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 L 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 L 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 L 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 L 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 L 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 L 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 L 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 L 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 L 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 L 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 L 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 L 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 L 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 L 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 L 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 L 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 L 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 L 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 L 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 L 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 L 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 L 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 L 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 L 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 L 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 L 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 L 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 L 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 L 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 L 432 CYS VAL LYS MODRES 3EVJ ASN I 96 ASN GLYCOSYLATION SITE MODRES 3EVJ ASN I 155 ASN GLYCOSYLATION SITE MODRES 3EVJ ASN I 192 ASN GLYCOSYLATION SITE MODRES 3EVJ ASN L 96 ASN GLYCOSYLATION SITE MODRES 3EVJ ASN L 155 ASN GLYCOSYLATION SITE MODRES 3EVJ ASN L 192 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 13 HET MAN A 3 11 HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET MAN D 3 11 HET MAN D 4 11 HET MAN D 5 11 HET ZDO E 1 21 HET IDS E 2 16 HET SUS E 3 23 HET BDP E 4 12 HET SGN E 5 19 HET ZDO F 1 21 HET IDS F 2 16 HET SUS F 3 23 HET BDP F 4 12 HET SGN F 5 19 HET NAG I 801 14 HET NAG L 801 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM ZDO METHYL 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D- HETNAM 2 ZDO GLUCOPYRANOSIDE HETNAM IDS 2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID HETNAM SUS 2-DEOXY-3,6-DI-O-SULFO-2-(SULFOAMINO)-ALPHA-D- HETNAM 2 SUS GLUCOPYRANOSE HETNAM BDP BETA-D-GLUCOPYRANURONIC ACID HETNAM SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN IDS O2-SULFO-GLUCURONIC ACID; 2-O-SULFO-ALPHA-L-IDURONIC HETSYN 2 IDS ACID; 2-O-SULFO-L-IDURONIC ACID; 2-O-SULFO-IDURONIC HETSYN 3 IDS ACID HETSYN SUS 3,6-DI-O-SULFO-N-SULFO-ALPHA-D-GLUCOSAMINE; 2-DEOXY-3, HETSYN 2 SUS 6-DI-O-SULFO-2-(SULFOAMINO)-ALPHA-D-GLUCOSE; 2-DEOXY- HETSYN 3 SUS 3,6-DI-O-SULFO-2-(SULFOAMINO)-D-GLUCOSE; 2-DEOXY-3,6- HETSYN 4 SUS DI-O-SULFO-2-(SULFOAMINO)-GLUCOSE HETSYN BDP BETA-D-GLUCURONIC ACID; D-GLUCURONIC ACID; GLUCURONIC HETSYN 2 BDP ACID HETSYN SGN N,O6-DISULFO-GLUCOSAMINE; 6-O-SULFO-N-SULFO-ALPHA-D- HETSYN 2 SGN GLUCOSAMINE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D- HETSYN 3 SGN GLUCOSE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-D-GLUCOSE; HETSYN 4 SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-GLUCOSE FORMUL 3 NAG 10(C8 H15 N O6) FORMUL 3 MAN 4(C6 H12 O6) FORMUL 7 ZDO 2(C7 H15 N O11 S2) FORMUL 7 IDS 2(C6 H10 O10 S) FORMUL 7 SUS 2(C6 H13 N O14 S3) FORMUL 7 BDP 2(C6 H10 O7) FORMUL 7 SGN 2(C6 H13 N O11 S2) FORMUL 11 HOH *45(H2 O) HELIX 1 1 LYS I 11 ILE I 15 5 5 HELIX 2 2 ASN I 45 LYS I 70 1 26 HELIX 3 3 SER I 79 LYS I 91 1 13 HELIX 4 4 CYS I 95 PHE I 106 1 12 HELIX 5 5 SER I 112 GLN I 118 1 7 HELIX 6 6 GLN I 118 ARG I 132 1 15 HELIX 7 7 ASN I 155 TYR I 166 1 12 HELIX 8 8 GLU I 180 GLU I 195 1 16 HELIX 9 9 SER I 230 THR I 234 5 5 HELIX 10 10 ALA I 264 GLY I 266 5 3 HELIX 11 11 SER I 291 LYS I 297 1 7 HELIX 12 12 THR I 300 LEU I 311 1 12 HELIX 13 13 LEU I 331 ASP I 337 1 7 HELIX 14 14 VAL I 341 SER I 345 5 5 HELIX 15 15 ASP L 6 ALA L 10 5 5 HELIX 16 16 ASN L 45 ASP L 68 1 24 HELIX 17 17 SER L 79 LEU L 92 1 14 HELIX 18 18 ASN L 96 PHE L 106 1 11 HELIX 19 19 SER L 112 ASP L 117 1 6 HELIX 20 20 GLN L 118 ARG L 132 1 15 HELIX 21 21 ASN L 155 TYR L 166 1 12 HELIX 22 22 ASN L 178 THR L 194 1 17 HELIX 23 23 SER L 230 THR L 234 5 5 HELIX 24 24 ALA L 264 GLY L 266 5 3 HELIX 25 25 LEU L 292 LYS L 297 1 6 HELIX 26 26 THR L 300 LEU L 311 1 12 HELIX 27 27 LEU L 331 GLY L 339 1 9 HELIX 28 28 VAL L 341 SER L 345 5 5 HELIX 29 29 PRO L 416 ASN L 418 5 3 SHEET 1 A 7 ILE I 76 LEU I 78 0 SHEET 2 A 7 THR I 419 VAL I 426 -1 O MET I 423 N LEU I 78 SHEET 3 A 7 PHE I 408 GLU I 414 -1 N VAL I 410 O GLY I 424 SHEET 4 A 7 ILE I 279 LEU I 285 -1 N THR I 280 O ARG I 413 SHEET 5 A 7 GLN I 268 PRO I 273 -1 N GLN I 268 O LEU I 285 SHEET 6 A 7 MET I 251 ARG I 262 -1 N ARG I 259 O GLU I 271 SHEET 7 A 7 GLU I 312 PRO I 321 -1 O GLU I 312 N TYR I 260 SHEET 1 B 6 GLN I 171 PRO I 172 0 SHEET 2 B 6 SER I 142 GLY I 148 1 N LEU I 146 O GLN I 171 SHEET 3 B 6 LEU I 213 TYR I 220 -1 O VAL I 214 N PHE I 147 SHEET 4 B 6 VAL I 364 ASN I 376 1 O LYS I 370 N ILE I 219 SHEET 5 B 6 GLY I 379 SER I 380 -1 O GLY I 379 N ASN I 376 SHEET 6 B 6 GLY I 223 LEU I 224 -1 N GLY I 223 O SER I 380 SHEET 1 C 5 GLN I 171 PRO I 172 0 SHEET 2 C 5 SER I 142 GLY I 148 1 N LEU I 146 O GLN I 171 SHEET 3 C 5 LEU I 213 TYR I 220 -1 O VAL I 214 N PHE I 147 SHEET 4 C 5 VAL I 364 ASN I 376 1 O LYS I 370 N ILE I 219 SHEET 5 C 5 PHE I 323 SER I 330 -1 N PHE I 323 O VAL I 375 SHEET 1 D 2 LEU I 238 TYR I 240 0 SHEET 2 D 2 SER I 246 SER I 248 -1 O CYS I 247 N PHE I 239 SHEET 1 E 4 ALA I 387 ILE I 390 0 SHEET 2 E 4 GLU L 312 PRO L 321 1 O HIS L 319 N VAL I 389 SHEET 3 E 4 SER L 246 TYR L 260 -1 N GLN L 254 O VAL L 318 SHEET 4 E 4 ARG L 235 TYR L 240 -1 N PHE L 239 O CYS L 247 SHEET 1 F 5 ILE L 76 LEU L 78 0 SHEET 2 F 5 THR L 419 VAL L 426 -1 O ARG L 425 N ILE L 76 SHEET 3 F 5 PHE L 408 GLU L 414 -1 N ILE L 412 O ILE L 421 SHEET 4 F 5 ILE L 279 ILE L 284 -1 N ILE L 284 O LEU L 409 SHEET 5 F 5 LEU L 270 PRO L 273 -1 N LEU L 272 O MET L 281 SHEET 1 G 6 ALA L 168 LEU L 173 0 SHEET 2 G 6 SER L 138 ASP L 149 1 N LEU L 146 O LYS L 169 SHEET 3 G 6 LEU L 213 LEU L 224 -1 O VAL L 214 N PHE L 147 SHEET 4 G 6 GLY L 379 VAL L 389 -1 O VAL L 388 N LEU L 215 SHEET 5 G 6 ASP L 366 VAL L 375 -1 N PHE L 368 O ALA L 387 SHEET 6 G 6 ARG L 324 SER L 330 -1 N ASP L 327 O ALA L 371 SHEET 1 H 2 THR L 153 PHE L 154 0 SHEET 2 H 2 VAL L 355 GLU L 357 -1 O ALA L 356 N THR L 153 SHEET 1 I 2 ARG L 262 VAL L 263 0 SHEET 2 I 2 THR L 267 GLN L 268 -1 O THR L 267 N VAL L 263 SSBOND 1 CYS I 8 CYS I 128 1555 1555 2.05 SSBOND 2 CYS I 21 CYS I 95 1555 1555 2.04 SSBOND 3 CYS I 247 CYS I 430 1555 1555 2.04 SSBOND 4 CYS L 8 CYS L 128 1555 1555 2.05 SSBOND 5 CYS L 21 CYS L 95 1555 1555 2.01 SSBOND 6 CYS L 247 CYS L 430 1555 1555 2.04 LINK ND2 ASN I 96 C1 NAG I 801 1555 1555 1.45 LINK ND2 ASN I 155 C1 NAG A 1 1555 1555 1.44 LINK ND2 ASN I 192 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN L 96 C1 NAG L 801 1555 1555 1.45 LINK ND2 ASN L 155 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN L 192 C1 NAG D 1 1555 1555 1.45 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.38 LINK O4 NAG A 2 C1 MAN A 3 1555 1555 1.39 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.41 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK O4 NAG D 2 C1 MAN D 3 1555 1555 1.39 LINK O3 MAN D 3 C1 MAN D 4 1555 1555 1.41 LINK O6 MAN D 3 C1 MAN D 5 1555 1555 1.41 LINK O4 ZDO E 1 C1 IDS E 2 1555 1555 1.44 LINK O4 IDS E 2 C1 SUS E 3 1555 1555 1.44 LINK O4 SUS E 3 C1 BDP E 4 1555 1555 1.44 LINK O4 BDP E 4 C1 SGN E 5 1555 1555 1.44 LINK O4 ZDO F 1 C1 IDS F 2 1555 1555 1.44 LINK O4 IDS F 2 C1 SUS F 3 1555 1555 1.43 LINK O4 SUS F 3 C1 BDP F 4 1555 1555 1.44 LINK O4 BDP F 4 C1 SGN F 5 1555 1555 1.44 CISPEP 1 VAL I 415 PRO I 416 0 -0.09 CRYST1 65.846 87.055 92.383 90.00 106.18 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015187 0.000000 0.004408 0.00000 SCALE2 0.000000 0.011487 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011271 0.00000